pSivida’s UK subsidiary pSiMedica has added to its team, appointing Texan professor Jeffrey Coffer as a collaborator. Professor Coffer’s professional background includes research into semiconductor nanocrystal synthesis, properties and characterization, with particular reference to porous silicon. pSivida, a local listed nanotechnology company, is developing porous silicon medical applications in drug delivery and orthopaedics for its trademarked product BioSilicon.
Professor Coffer has focused his most recent research in BioSilicon™ in the fields of orthopaedics and tissue engineering, as well as researching silicon nanowires and rare earth incorporation into porous silicon for optoelectrical and biomedical applications.
© Business News 2017. You may share content using the tools provided but do not copy and redistribute.